32 BIOSCIENCES TO LAUNCH $40 MLN SERIES A AT J.P. MORGAN TO ADVANCE FIRST-IN-CLASS GI MUCOSAL-IMMUNE THERAPEUTICS

Reuters · 4d ago

Please log in to view news